Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.

作者: John M. Fitzpatrick , François Desgrandchamps , Kamel Adjali , Lauro Gomez Guerra , Sung Joon Hong

DOI: 10.1111/J.1464-410X.2011.10430.X

关键词:

摘要: OBJECTIVES To evaluate the management of acute urinary retention (AUR) associated with benign prostatic hyperplasia (BPH) in real-life practice. To identify predictors successful trial without catheter (TWOC). MATERIALS AND METHODS In all, 6074 men catheterized for painful AUR were enrolled a prospective, cross-sectional survey conducted public and private urology practices France, Asia, Latin America, Algeria Middle East. Patient clinical characteristics, type its (type catheterization, hospitalization, TWOC, use α1-blockers, immediate or elective surgery) adverse events observed during catheterization period recorded. Predictors TWOC success also analysed by multivariate regression analysis stepwise procedure. RESULTS Of men, 4289 (71%) had spontaneous 1785 (29%) precipitated AUR, mainly as result loco-regional/general anaesthesia (28.5%) excessive alcohol intake (18.2%). Presence BPH was revealed 44% men. Hospitalization varied between countries, ranging from 1.7% to 100% France. A urethral inserted most cases (89.8%) usually followed (78.0%) after median 5 days. Overall rate 61%. Most (86%) received an α1-blocker (mainly alfuzosin) before removal consistently higher rates, regardless age AUR. Multivariate confirmed that doubled chances (odds ratio 1.92, 95% CI 1.52–2.42, P < 0.001). Age ≥70 years, prostate size ≥50 g, severe lower tract symptoms, drained volume at ≥1000 mL favoured failure. Catheterization >3 days did not influence but increased morbidity prolonged hospitalization events. In case failure, 49% recatheterized surgery 43.5% tried another 29.5%. Elective preferred surgery. CONCLUSIONS TWOC has become standard practice worldwide AUR. In cases, is prescribed significantly increases chance success. Prolonged morbidity.

参考文章(21)
FRANCOIS DESGRANDCHAMPS, ALEXANDRE DE LA TAILLE, JEAN-DOMINIQUE DOUBLET, , The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia. BJUI. ,vol. 97, pp. 727- 733 ,(2006) , 10.1111/J.1464-410X.2006.06109.X
AS McNeill, S Rizvi, DJ Byrne, None, Prostate Size Influences the Outcome After Presenting With Acute Urinary Retention The Journal of Urology. ,vol. 175, pp. 227- 228 ,(2006) , 10.1016/S0022-5347(05)00194-1
SA McNeill, TB Hargreave, Claus G Roehrborn, Alfaur Study Group, Alfuzosin 10 mg once daily in the management of acute urinary retention: Results of a double-blind placebo-controlled study Urology. ,vol. 65, pp. 83- 89 ,(2005) , 10.1016/J.UROLOGY.2004.07.042
R. Manikandan, S.J. Srirangam, P.H. O'Reilly, G.N. Collins, Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey BJUI. ,vol. 93, pp. 84- 88 ,(2004) , 10.1111/J.1464-410X.2004.04562.X
Steven J. Jacobsen, Debra J. Jacobson, Cynthia J. Girman, Rosebud O. Roberts, Thomas Rhodes, Harry A. Guess, Michael M. Lieber, Natural History of Prostatism: Risk Factors for Acute Urinary Retention Journal of Urology. ,vol. 158, pp. 481- 487 ,(1997) , 10.1016/S0022-5347(01)64508-7
S.A. MCNEILL, T.B. HARGREAVE, , Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention The Journal of Urology. ,vol. 171, pp. 2316- 2320 ,(2005) , 10.1097/01.JU.0000127743.80759.7A
Pickard, Emberton, Neal on behalf of the National Pros, The management of men with acute urinary retention BJUI. ,vol. 81, pp. 712- 720 ,(1998) , 10.1046/J.1464-410X.1998.00632.X
Paul Cathcart, Jan van der Meulen, Jim Armitage, Mark Emberton, Incidence of Primary and Recurrent Acute Urinary Retention Between 1998 and 2003 in England The Journal of Urology. ,vol. 176, pp. 200- 204 ,(2006) , 10.1016/S0022-5347(06)00509-X